Implementing HIV testing in opioid treatment programs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to enhance the provision of HIV and Hepatitis C testing within opioid treatment programs (OTPs) through two evidence-based practice coaching interventions. The study will randomly assign 51 OTP sites to either an information control group or one of the two active coaching interventions focused on HIV testing and linkage to care. The effectiveness of these interventions will be evaluated based on patient uptake of testing, initiation of services, and health outcomes over time. Data will be collected on patient demographics, testing rates, and healthcare utilization to assess the impact of the interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Eligible sites must:

  1. See at least 150 unduplicated patients/year/site
  2. Be capable and willing to prospectively collect data on the number of patients who a) are offered any HIV and/or HCV tests; b) completed these tests; c) are referred to care/evaluation (and type of referral) if positive; and d) are linked to care/evaluation within 30 days of diagnosis
  3. Be capable and willing to provide patient demographics, testing data within demographic categories of gender and race/ethnicity (in aggregate) and data on HIV/HCV test reimbursement processes and outcomes
  4. Have key staff willing to consent to participate in study surveys, qualitative interviews and intervention coaching throughout the study

Exclusion Criteria:

* Sites will be excluded if:

  1. Over 50% of patients served in the prior 6 months were HIV or HCV tested
  2. They are terminated via PI decision/discretion

Where it's running

• Columbia University Medical Center
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Lisa Metsch, PhD — Columbia University
• Study coordinator: Lauren Gooden, PhD
• Email: lkg2129@columbia.edu
• Phone: 786-703-9819

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of MOUD Policy Changes During the Pandemic on Opioid and Alcohol Use Disorders

  This study tests how federal and state policy changes during the COVID-19 pandemic affected access to and use of medications for opioid use disorder among Veterans with opioid or alcohol use disorders.

  Recruiting Boston University · Boston, Massachusetts · NCT07232641

• HEAT telemedicine program for HIV and addiction care

  This project will try a telemedicine program to deliver addiction treatment to adults living with HIV in Alabama who report opioid or stimulant misuse.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT06370481

• Engagement of community health workers to support recovery from substance use disorders

  This study is testing whether support from community health workers can help people with substance use disorders engage better in treatment and improve their recovery experience after visiting the emergency department.

  Recruiting University of California, Los Angeles · Providence, Rhode Island · NCT06320015

• Community-based program for youth with opioid use disorder

  This study is testing a community program that helps young people with opioid use disorder get better treatment and support to see if it keeps them engaged in recovery and reduces overdoses.

  Recruiting Phase 4 The University of Texas Health Science Center, Houston · Houston, Texas · NCT04811014

• Using focused ultrasound to treat opioid and substance use disorders

  This study is testing whether a new ultrasound treatment can help people with opioid and substance use disorders feel better and manage their conditions safely.

  Recruiting at 3 sites InSightec · Tampa, Florida and 3 other locations · NCT04197921

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.